Schonfeld Strategic Advisors’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-217,434	Closed	-$6.56M	–	2730
2025 Q4	$6.56M	Buy	217,434 +159,506	+275%	+$4.37M	0.03%	465
2025 Q3	$1.11M	Sell	57,928 -80,823	-58%	-$1.46M	0.01%	1312
2025 Q2	$1.94M	Buy	138,751 +57,242	+70%	+$777K	0.01%	1007
2025 Q1	$1.1M	Sell	81,509 -589,091	-88%	-$10M	0.01%	1244
2024 Q4	$12.9M	Sell	670,600 -92,518	-12%	-$2.01M	0.08%	246
2024 Q3	$17.4M	Buy	763,118 +617,365	+424%	+$10.1M	0.14%	172
2024 Q2	$1.9M	Sell	145,753 -18,260	-11%	-$253K	0.01%	933
2024 Q1	$2.87M	Sell	164,013 -14,906	-8%	-$289K	0.02%	859
2023 Q4	$3.9M	Buy	178,919 +70,882	+66%	+$1.12M	0.03%	585
2023 Q3	$1.66M	Buy	108,037 +84,670	+362%	+$1.62M	0.02%	878
2023 Q2	$556K	Buy	+23,367	New	+$599K	﹤0.01%	1184
2023 Q1	–	Sell	-31,400	Closed	-$917K	–	2696
2022 Q4	$917K	Sell	31,400 -21,223	-40%	-$489K	0.01%	1198
2022 Q3	$945K	Buy	+52,623	New	+$946K	0.01%	1308
2022 Q1	–	Sell	-21,512	Closed	-$425K	–	2972
2021 Q4	$425K	Sell	21,512 -22,488	-51%	-$419K	﹤0.01%	1343
2021 Q3	$724K	Buy	+44,000	New	+$645K	0.01%	1099